|
|
|
 |
| Location: Home -
Products - Reference Compounds&Impurities - Anti-Cancer(Oncology) Agents
|
Momelotinib(CYT387)
| Catalogue No. : |
C14705 |
| Product Name: |
Momelotinib(CYT387) |
| Synonym: |
CYT 11387;CYT 387;CYT-387;Cyt387;Cyt-387;Momelotinib;CYT387 |
| Chemical Name: |
N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide |
| CAS No. : |
1056634-68-4 |
| Structure : |
|
| Molecular Formula: |
C23H22N6O2 |
| Molecular Weight: |
414.46 |
| Purity: |
>98% |
| Usage: |
CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively. CYT387 is useful for treatment of myeloproliferative disorders and anti-cancer. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
